» Articles » PMID: 24735451

"Clozapine Makes Me Quite Drowsy, So when I Wake Up in the Morning Those First Cups of Coffee Are Really Handy": an Exploratory Qualitative Study of Excessive Caffeine Consumption Among Individuals with Schizophrenia

Overview
Journal BMC Psychiatry
Publisher Biomed Central
Specialty Psychiatry
Date 2014 Apr 17
PMID 24735451
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Research has shown that individuals with schizophrenia use caffeine at higher rates than the general population; however, no qualitative research has been undertaken investigating problematic caffeine use and its effects on this population. This article explores the role of caffeine consumption in the lives of people with schizophrenia through a narrative analysis of the attitudes and beliefs associated with this practice, and how these, in turn, influence caffeine consumption.

Methods: A qualitative study was undertaken with individuals who had previously scored in either a 'moderate' or 'high' risk category for caffeine use on the Alcohol, Smoking and Substance Involvement Screening Tool (ASSIST). In-depth interviews were undertaken with 20 individuals, and transcripts were analysed thematically to identify prominent perspectives.

Results: Consistent with previous literature, participants' caffeine consumption was driven largely by its stimulating properties; however, participants also identified 'cravings' as an important motivating factor. Participants' behaviours related to caffeine consumption seemed to be tempered by their previous experiences of consumption; if participants had experienced positive effects such as alertness or relaxation in the past, their use was maintained at a similar level or increased. Conversely, participants who anticipated negative consequences often altered their patterns of caffeine consumption; for example, by substituting caffeinated drinks that minimised or ceased their experience of negative side effects for those that directly caused such impacts. Overall, participants largely identified caffeine consumption as a highly meaningful activity, which provided structure to their day and facilitated opportunities for social interaction.

Conclusions: The inconsistencies between individuals' beliefs about their health and the actual risk of harm associated with health-related behaviours present significant and ongoing challenges for the implementation of relevant and effective strategies for health promotion among individuals diagnosed with mental illness. As a starting point, it would be worthwhile for services engaging with people diagnosed with mental illness, and in particular schizophrenia, to consider implementing caffeine-related health literacy strategies to educate consumers about the risk of excessive caffeine consumption and the interactions between caffeine and antipsychotic medications.

Citing Articles

Light-Dark and Activity Rhythm Therapy (L-DART) to Improve Sleep in People with Schizophrenia Spectrum Disorders: A Single-Group Mixed Methods Study of Feasibility, Acceptability and Adherence.

Faulkner S, Didikoglu A, Byrne R, Drake R, Bee P Clocks Sleep. 2023; 5(4):734-754.

PMID: 38131747 PMC: 10742153. DOI: 10.3390/clockssleep5040048.


Risk and protective factors of relapse in patients with first-episode schizophrenia from perspectives of health professionals: a qualitative study in northeastern Thailand.

Intharit J, Kittiwattanagul K, Chaveepojnkamjorn W, Tudpor K F1000Res. 2022; 10:499.

PMID: 36033234 PMC: 9379331. DOI: 10.12688/f1000research.53317.1.


EEG Microstates in Early Phase Psychosis: The Effects of Acute Caffeine Consumption.

Bissonnette J, Anderson T, McKearney K, Tibbo P, Fisher D Clin EEG Neurosci. 2022; 53(4):335-343.

PMID: 35257622 PMC: 9174612. DOI: 10.1177/15500594221084994.


Fusing Sensor Paradigms to Acquire Chemical Information: An Integrative Role for Smart Biopolymeric Hydrogels.

Kim E, Liu Y, Ben-Yoav H, Winkler T, Yan K, Shi X Adv Healthc Mater. 2016; 5(20):2595-2616.

PMID: 27616350 PMC: 5485850. DOI: 10.1002/adhm.201600516.

References
1.
Moskowitz D, Young S . Ecological momentary assessment: what it is and why it is a method of the future in clinical psychopharmacology. J Psychiatry Neurosci. 2006; 31(1):13-20. PMC: 1325062. View

2.
Jones H, Griffiths R . Oral caffeine maintenance potentiates the reinforcing and stimulant subjective effects of intravenous nicotine in cigarette smokers. Psychopharmacology (Berl). 2002; 165(3):280-90. DOI: 10.1007/s00213-002-1262-4. View

3.
. WHO opens public consultation on draft sugars guideline. Cent Eur J Public Health. 2014; 22(1):41. View

4.
Gurpegui M, Aguilar M, Martinez-Ortega J, Jurado D, Diaz F, Quintana H . Fewer but heavier caffeine consumers in schizophrenia: a case-control study. Schizophr Res. 2006; 86(1-3):276-83. DOI: 10.1016/j.schres.2006.04.022. View

5.
FOWLER I, Carr V, Carter N, Lewin T . Patterns of current and lifetime substance use in schizophrenia. Schizophr Bull. 1998; 24(3):443-55. DOI: 10.1093/oxfordjournals.schbul.a033339. View